Financings in Brief: Norian
This article was originally published in The Gray Sheet
Executive Summary
Norian: Cupertino, California-based developer of the Norian Skeletal Repair System files registration statement with SEC for an initial public offering of 3 mil. shares, expected to be priced between $12 and $14 each. Underwriters Alex. Brown and Robertson, Stephens have an over-allotment option to buy up to 450,000 additional shares. Norian's SRS system incorporates an "injectable, moldable and biocompatible cancellous bone fixation and replacement material" for fracture treatment...